U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509450) titled 'Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study' on March 10.
Brief Summary: This is a single site pilot trial will evaluate the feasibility and safety of fecal microbiota transplantation (FMT) in patients with B-cell lymphoma who are undergoing CAR-T or in patients with moderate to high-risk acute myeloid leukemia or myelodysplastic syndrome who are undergoing allogeneic stem cell transplantation.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Lymphoma Receiving CAR-T Therapy
Intervention:
BIOLOGICAL: Fecal Mi...